Sponsor Pipeline

Phathom Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-07 NCT07752407 A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 3
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07752407 A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for… Symptomatic Non-erosive Gastroesophageal Reflux Disease Not Yet Recruiting
Phase 2
NCT06851559 A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo… Eosinophilic Esophagitis Active, Not Recruiting
Not specified
NCT06660342 A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring Erosive Esophagitis Recruiting
Get alerts when Phathom Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free